1205 related articles for article (PubMed ID: 27825189)
1. Exhaled nitric oxide levels to guide treatment for children with asthma.
Petsky HL; Kew KM; Chang AB
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011439. PubMed ID: 27825189
[TBL] [Abstract][Full Text] [Related]
2. Exhaled nitric oxide levels to guide treatment for adults with asthma.
Petsky HL; Kew KM; Turner C; Chang AB
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD011440. PubMed ID: 27580628
[TBL] [Abstract][Full Text] [Related]
3. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
Petsky HL; Cates CJ; Li A; Kynaston JA; Turner C; Chang AB
Cochrane Database Syst Rev; 2009 Oct; (4):CD006340. PubMed ID: 19821360
[TBL] [Abstract][Full Text] [Related]
4. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults.
Petsky HL; Cates CJ; Li AM; Kynaston JA; Turner C; Chang AB
Cochrane Database Syst Rev; 2008 Apr; (2):CD006340. PubMed ID: 18425949
[TBL] [Abstract][Full Text] [Related]
5. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
Petsky HL; Li A; Chang AB
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221
[TBL] [Abstract][Full Text] [Related]
6. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils).
Petsky HL; Cates CJ; Lasserson TJ; Li AM; Turner C; Kynaston JA; Chang AB
Thorax; 2012 Mar; 67(3):199-208. PubMed ID: 20937641
[TBL] [Abstract][Full Text] [Related]
7. Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.
Chauhan BF; Jeyaraman MM; Singh Mann A; Lys J; Abou-Setta AM; Zarychanski R; Ducharme FM
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010347. PubMed ID: 28301050
[TBL] [Abstract][Full Text] [Related]
8. Interventions for managing asthma in pregnancy.
Bain E; Pierides KL; Clifton VL; Hodyl NA; Stark MJ; Crowther CA; Middleton P
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD010660. PubMed ID: 25331331
[TBL] [Abstract][Full Text] [Related]
9. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
[TBL] [Abstract][Full Text] [Related]
10. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
[TBL] [Abstract][Full Text] [Related]
11. Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults.
Chong J; Haran C; Chauhan BF; Asher I
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD011032. PubMed ID: 26197430
[TBL] [Abstract][Full Text] [Related]
12. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.
Kew KM; Quinn M; Quon BS; Ducharme FM
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD007524. PubMed ID: 27272563
[TBL] [Abstract][Full Text] [Related]
13. Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children.
Kew KM; Flemyng E; Quon BS; Leung C
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD007524. PubMed ID: 36161875
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D for the management of asthma.
Williamson A; Martineau AR; Sheikh A; Jolliffe D; Griffiths CJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD011511. PubMed ID: 36744416
[TBL] [Abstract][Full Text] [Related]
15. Interventions to improve adherence to inhaled steroids for asthma.
Normansell R; Kew KM; Stovold E
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012226. PubMed ID: 28417456
[TBL] [Abstract][Full Text] [Related]
16. The Breathing for Life Trial: a randomised controlled trial of fractional exhaled nitric oxide (FENO)-based management of asthma during pregnancy and its impact on perinatal outcomes and infant and childhood respiratory health.
Murphy VE; Jensen ME; Mattes J; Hensley MJ; Giles WB; Peek MJ; Bisits A; Callaway LK; McCaffery K; Barrett HL; Colditz PB; Seeho SK; Attia J; Searles A; Doran C; Powell H; Gibson PG
BMC Pregnancy Childbirth; 2016 May; 16():111. PubMed ID: 27189595
[TBL] [Abstract][Full Text] [Related]
17. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
Anderson DE; Kew KM; Boyter AC
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488
[TBL] [Abstract][Full Text] [Related]
18. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults.
Petsky HL; Kynaston JA; Turner C; Li AM; Cates CJ; Lasserson TJ; Chang AB
Cochrane Database Syst Rev; 2007 Apr; (2):CD005603. PubMed ID: 17443604
[TBL] [Abstract][Full Text] [Related]
19. Stopping long-acting beta2-agonists (LABA) for adults with asthma well controlled by LABA and inhaled corticosteroids.
Ahmad S; Kew KM; Normansell R
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011306. PubMed ID: 26089258
[TBL] [Abstract][Full Text] [Related]
20. Different oral corticosteroid regimens for acute asthma.
Normansell R; Kew KM; Mansour G
Cochrane Database Syst Rev; 2016 May; 2016(5):CD011801. PubMed ID: 27176676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
